Bank of America’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $147M | Buy |
976,793
+81,572
| +9% | +$8.87M | 0.01% | 944 |
|
|
2026
Q1 | $82.7M | Sell |
895,221
-122,425
| -12% | -$12.3M | 0.01% | 1261 |
|
|
2025
Q4 | $104M | Buy |
1,017,646
+143,788
| +16% | +$12.9M | 0.01% | 1084 |
|
|
2025
Q3 | $54.6M | Buy |
873,858
+166,454
| +24% | +$9.05M | ﹤0.01% | 1672 |
|
|
2025
Q2 | $36.8M | Buy |
707,404
+221,039
| +45% | +$9.87M | ﹤0.01% | 1961 |
|
|
2025
Q1 | $20.7M | Buy |
486,365
+26,754
| +6% | +$1.15M | ﹤0.01% | 2396 |
|
|
2024
Q4 | $14M | Sell |
459,611
-306,673
| -40% | -$8.63M | ﹤0.01% | 2607 |
|
|
2024
Q3 | $17.6M | Buy |
766,284
+335,784
| +78% | +$9.5M | ﹤0.01% | 2527 |
|
|
2024
Q2 | $12.4M | Sell |
430,500
-99,104
| -19% | -$2.31M | ﹤0.01% | 2723 |
|
|
2024
Q1 | $10.9M | Sell |
529,604
-76,914
| -13% | -$1.65M | ﹤0.01% | 2909 |
|
|
2023
Q4 | $16.4M | Sell |
606,518
-146,372
| -19% | -$3.84M | ﹤0.01% | 2367 |
|
|
2023
Q3 | $22.3M | Buy |
752,890
+91,962
| +14% | +$3.23M | ﹤0.01% | 1917 |
|
|
2023
Q2 | $23.7M | Sell |
660,928
-378,099
| -36% | -$10.9M | ﹤0.01% | 1868 |
|
|
2023
Q1 | $24.4M | Buy |
1,039,027
+348,120
| +50% | +$9.94M | ﹤0.01% | 1945 |
|
|
2022
Q4 | $18.8M | Sell |
690,907
-288,288
| -29% | -$13.2M | ﹤0.01% | 2072 |
|
|
2022
Q3 | $52.7M | Buy |
979,195
+136,376
| +16% | +$7M | 0.01% | 1232 |
|
|
2022
Q2 | $34M | Sell |
842,819
-81,515
| -9% | -$4.04M | ﹤0.01% | 1544 |
|
|
2022
Q1 | $61.2M | Sell |
924,334
-202,517
| -18% | -$13.9M | 0.01% | 1222 |
|
|
2021
Q4 | $113M | Sell |
1,126,851
-88,098
| -7% | -$9.11M | 0.01% | 936 |
|
|
2021
Q3 | $152M | Buy |
1,214,949
+4,343
| +0.4% | +$516K | 0.02% | 753 |
|
|
2021
Q2 | $150M | Buy |
1,210,606
+149,523
| +14% | +$20.1M | 0.02% | 761 |
|
|
2021
Q1 | $162M | Sell |
1,061,083
-89,808
| -8% | -$13.6M | 0.02% | 669 |
|
|
2020
Q4 | $148M | Buy |
1,150,891
+211,085
| +22% | +$24.3M | 0.02% | 628 |
|
|
2020
Q3 | $105M | Buy |
939,806
+33,312
| +4% | +$3.05M | 0.01% | 712 |
|
|
2020
Q2 | $73.5M | Buy |
906,494
+296,407
| +49% | +$23.9M | 0.01% | 839 |
|
|
2020
Q1 | $42.5M | Buy |
610,087
+349,668
| +134% | +$26.8M | 0.01% | 1038 |
|
|
2019
Q4 | $20.3M | Buy |
260,419
+56,224
| +28% | +$4.05M | ﹤0.01% | 1867 |
|
|
2019
Q3 | $13M | Buy |
204,195
+67,647
| +50% | +$5.96M | ﹤0.01% | 2236 |
|
|
2019
Q2 | $11.8M | Buy |
136,548
+109,878
| +412% | +$8.39M | ﹤0.01% | 2374 |
|
|
2019
Q1 | $2.04M | Buy |
26,670
+20,028
| +302% | +$1.11M | ﹤0.01% | 3976 |
|
|
2018
Q4 | $250K | Buy |
+6,642
| New | +$245K | ﹤0.01% | 5380 |
|
Other funds holding GH
DTC
Bank of America's GH Position: Q2 2026 in Review
Bank of America increased its Guardant Health (GH) stake by 9.1% in Q2 2026, buying an estimated $8.87M and bringing the position to 976,793 shares worth $147M. The position accounts for 0.01% of the portfolio, ranked #944.
Bank of America first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $162M in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Bank of America held 976,793 shares of Guardant Health worth $147M as of Q2 2026.
- Bank of America bought 81,572 Guardant Health shares in Q2 2026, an estimated $8.87M.
- Guardant Health made up 0.01% of Bank of America's portfolio in Q2 2026, its #944 holding.
- Bank of America first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- Bank of America's Guardant Health position peaked at $162M in Q1 2021.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.